159 related articles for article (PubMed ID: 27596531)
1. In-silico Hierarchical Approach for the Identification of Potential Universal Vaccine Candidates (PUVCs) from Neisseria gonorrhoeae.
Jain R; Sonkar SC; Chaudhry U; Bala M; Saluja D
J Theor Biol; 2016 Dec; 410():36-43. PubMed ID: 27596531
[TBL] [Abstract][Full Text] [Related]
2. Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.
Zielke RA; Wierzbicki IH; Baarda BI; Gafken PR; Soge OO; Holmes KK; Jerse AE; Unemo M; Sikora AE
Mol Cell Proteomics; 2016 Jul; 15(7):2338-55. PubMed ID: 27141096
[TBL] [Abstract][Full Text] [Related]
3. Design and immune characterization of a novel Neisseria gonorrhoeae DNA vaccine using bacterial ghosts as vector and adjuvant.
Jiao H; Yang H; Zhao D; Chen J; Zhang Q; Liang J; Yin Y; Kong G; Li G
Vaccine; 2018 Jul; 36(30):4532-4539. PubMed ID: 29914847
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates.
Baarda BI; Zielke RA; Holm AK; Sikora AE
mSphere; 2021 Feb; 6(1):. PubMed ID: 33536323
[TBL] [Abstract][Full Text] [Related]
5. Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
Edwards JL; Jennings MP; Apicella MA; Seib KL
Crit Rev Microbiol; 2016 Nov; 42(6):928-41. PubMed ID: 26805040
[TBL] [Abstract][Full Text] [Related]
6. Neisseria gonorrhoeae vaccine development: hope on the horizon?
Edwards JL; Jennings MP; Seib KL
Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
[TBL] [Abstract][Full Text] [Related]
7. Could vaccination against Neisseria gonorrhoeae be on the horizon?
Russell MW
Future Microbiol; 2018 Apr; 13():495-497. PubMed ID: 29517283
[No Abstract] [Full Text] [Related]
8. Progress Toward a Gonococcal Vaccine: The Way Forward.
Russell MW; Jerse AE; Gray-Owen SD
Front Immunol; 2019; 10():2417. PubMed ID: 31681305
[TBL] [Abstract][Full Text] [Related]
9. Proteomics, Bioinformatics and Structure-Function Antigen Mining For Gonorrhea Vaccines.
Baarda BI; Martinez FG; Sikora AE
Front Immunol; 2018; 9():2793. PubMed ID: 30564232
[TBL] [Abstract][Full Text] [Related]
10. Strategies for mimicking Neisserial saccharide epitopes as vaccines.
Gulati S; Ngampasutadol J; Yamasaki R; McQuillen DP; Rice PA
Int Rev Immunol; 2001; 20(2):229-50. PubMed ID: 11878767
[TBL] [Abstract][Full Text] [Related]
11. Core proteome mediated therapeutic target mining and multi-epitope vaccine design for Helicobacter pylori.
Rahman N; Ajmal A; Ali F; Rastrelli L
Genomics; 2020 Sep; 112(5):3473-3483. PubMed ID: 32562830
[TBL] [Abstract][Full Text] [Related]
12. Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap.
Gottlieb SL; Jerse AE; Delany-Moretlwe S; Deal C; Giersing BK
Sex Health; 2019 Sep; 16(5):426-432. PubMed ID: 31476278
[TBL] [Abstract][Full Text] [Related]
13. Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection.
Gulati S; Zheng B; Reed GW; Su X; Cox AD; St Michael F; Stupak J; Lewis LA; Ram S; Rice PA
PLoS Pathog; 2013; 9(8):e1003559. PubMed ID: 24009500
[TBL] [Abstract][Full Text] [Related]
14. A pilus peptide vaccine for the prevention of gonorrhea.
Schoolnik GK; Tai JY; Gotschlich EC
Prog Allergy; 1983; 33():314-31. PubMed ID: 6187017
[No Abstract] [Full Text] [Related]
15. Characterization of exclusively non-commensal Neisseria gonorrhoeae pangenome to prioritize globally conserved and thermodynamically stable vaccine candidates using immune-molecular dynamic simulations.
Mahnoor I; Shabbir H; Nawaz S; Aziz K; Aziz U; Khalid K; Irum S; Andleeb S
Microb Pathog; 2023 Dec; 185():106439. PubMed ID: 37944674
[TBL] [Abstract][Full Text] [Related]
16. Proteome-wide B and T cell epitope repertoires in outer membrane proteins of Mycobacterium avium subsp. paratuberculosis have vaccine and diagnostic relevance: a holistic approach.
Rana A; Rub A; Akhter Y
J Mol Recognit; 2015 Aug; 28(8):506-20. PubMed ID: 25727233
[TBL] [Abstract][Full Text] [Related]
17. The potential impact of vaccination on the prevalence of gonorrhea.
Craig AP; Gray RT; Edwards JL; Apicella MA; Jennings MP; Wilson DP; Seib KL
Vaccine; 2015 Aug; 33(36):4520-4525. PubMed ID: 26192351
[TBL] [Abstract][Full Text] [Related]
18. Neisseria proteomics for antigen discovery and vaccine development.
Christodoulides M
Expert Rev Proteomics; 2014 Oct; 11(5):573-91. PubMed ID: 25017717
[TBL] [Abstract][Full Text] [Related]
19. A Web Resource for Designing Subunit Vaccine Against Major Pathogenic Species of Bacteria.
Nagpal G; Usmani SS; Raghava GPS
Front Immunol; 2018; 9():2280. PubMed ID: 30356876
[TBL] [Abstract][Full Text] [Related]
20. Vaccine research for gonococcal infections: where are we?
Jerse AE; Deal CD
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv63-8. PubMed ID: 24243883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]